Veltkamp M - Search Results

1

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients.

Peters BJM, Bhatoe A, Vorselaars ADM, Veltkamp M. Peters BJM, et al. Among authors: veltkamp m. Cells. 2021 Feb 19;10(2):441. doi: 10.3390/cells10020441. Cells. 2021. PMID: 33669641 Free PMC article. Review.

2

Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M, Thomeer M, van Moorsel CHM, Grutters JC. Vorselaars ADM, et al. Among authors: veltkamp m. Chest. 2013 Sep;144(3):805-812. doi: 10.1378/chest.12-1728. Chest. 2013. PMID: 23538719

3

Infliximab or biosimilars in sarcoidosis; to switch or not to switch?

Veltkamp M, Drent M, Baughman RP. Veltkamp M, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):280-3. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 26847093 No abstract available.

4

Efficacy and safety of infliximab biosimilar Inflectra^® in severe sarcoidosis.

Schimmelpennink MC, Vorselaars ADM, van Beek FT, Crommelin HA, Deneer VHM, Keijsers RGM, Veltkamp M. Schimmelpennink MC, et al. Among authors: veltkamp m. Respir Med. 2018 May;138S:S7-S13. doi: 10.1016/j.rmed.2018.02.009. Epub 2018 Feb 19. Respir Med. 2018. PMID: 29496351 Free article.

5

Quantification of pulmonary disease activity in sarcoidosis measured with ¹⁸F-FDG PET/CT: SUVmax versus total lung glycolysis.

Schimmelpennink MC, Vorselaars ADM, Veltkamp M, Keijsers RGM. Schimmelpennink MC, et al. Among authors: veltkamp m. EJNMMI Res. 2019 Jun 13;9(1):54. doi: 10.1186/s13550-019-0505-x. EJNMMI Res. 2019. PMID: 31197630 Free PMC article.

6

Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.

Schimmelpennink MC, Quanjel M, Vorselaars A, Wiertz I, Veltkamp M, Van Moorsel C, Grutters JC. Schimmelpennink MC, et al. Among authors: veltkamp m. Expert Rev Respir Med. 2020 Jul;14(7):749-756. doi: 10.1080/17476348.2020.1751614. Epub 2020 Apr 12. Expert Rev Respir Med. 2020. PMID: 32248706 Review.

7

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Kraaijvanger R, et al. Among authors: veltkamp m. Front Immunol. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443. eCollection 2020. Front Immunol. 2020. PMID: 32760396 Free PMC article. Review.

8

Effectiveness and safety of infliximab in cardiac Sarcoidosis.

Bakker ALM, Mathijssen H, Azzahhafi J, Swaans MJ, Veltkamp M, Keijsers RGM, Akdim F, Post MC, Grutters JC. Bakker ALM, et al. Among authors: veltkamp m. Int J Cardiol. 2021 May 1;330:179-185. doi: 10.1016/j.ijcard.2021.02.022. Epub 2021 Feb 12. Int J Cardiol. 2021. PMID: 33582196

9

Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype.

Beijer E, Roodenburg-Benschop C, Schimmelpennink MC, Grutters JC, Meek B, Veltkamp M. Beijer E, et al. Among authors: veltkamp m. Cells. 2021 Mar 7;10(3):585. doi: 10.3390/cells10030585. Cells. 2021. PMID: 33799927 Free PMC article.

10

A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren's Syndrome and Alters Receptor Expression as well as Functional Response.

Karakaya B, van Moorsel CHM, Veltkamp M, Roodenburg-Benschop C, Kazemier KM, van der Helm-van Mil AHM, Huizinga TWJ, Grutters JC, Rijkers GT. Karakaya B, et al. Among authors: veltkamp m. Cells. 2021 Aug 3;10(8):1967. doi: 10.3390/cells10081967. Cells. 2021. PMID: 34440736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page